JP MORGAN/CALL/MEDTRONIC/75/0.1/17.01.25 Share Price

Warrant

DE000JB3GA52

Real-time Bid/Ask 08:31:05 01/07/2024 pm IST
0.69 EUR / 0.7 EUR -4.79% Intraday chart for JP MORGAN/CALL/MEDTRONIC/75/0.1/17.01.25
Current month-16.09%
1 month-27.72%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/24/01 0.74 +1.37%
28/24/28 0.73 -5.19%
27/24/27 0.77 0.00%
26/24/26 0.77 -10.47%
25/24/25 0.86 -4.44%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 12:21 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer J.P. Morgan
WKN JB3GA5
ISINDE000JB3GA52
Date issued 10/10/2023
Strike 75 $
Maturity 17/01/2025 (200 Days)
Parity 10 : 1
Emission price 0.97
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.63
Lowest since issue 0.71
Spread 0.01
Spread %1.30%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus